Global Bone Metastasis Therapeutics Pipeline Report 2016 - Review of 16 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Bone Metastasis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Bone Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Metastasis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Bone Metastasis Overview
  3. Therapeutics Development
  4. Pipeline Products for Bone Metastasis - Overview
  5. Pipeline Products for Bone Metastasis - Comparative Analysis
  6. Bone Metastasis - Therapeutics under Development by Companies
  7. Bone Metastasis - Therapeutics under Investigation by Universities/Institutes
  8. Bone Metastasis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Bone Metastasis - Products under Development by Companies
  13. Bone Metastasis - Products under Investigation by Universities/Institutes
  14. Bone Metastasis - Companies Involved in Therapeutics Development
  • Ablynx NV
  • Alethia Biotherapeutics Inc.
  • Amgen Inc.
  • Amura Holdings Limited
  • Bayer AG
  • Campus Technologies Freiburg GmbH
  • ChemoCentryx, Inc.
  • Deciphera Pharmaceuticals, LLC
  • Oncobiologics, Inc.
  • Oncodrone BV
  • Osteologix Holdings Plc
  • R-Pharm
  • Sigma-Tau S.p.A.
  • Taiho Pharmaceutical Co., Ltd.
  • Terpenoid Therapeutics, Inc.
  • Thar Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/8wgmd9/bone_metastasis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs